Relative to Congenital Cytomegalovirus Awareness Month.

2025-2026 Regular Session Introduced by Cecilia Aguiar-Curry and 59 co-sponsors

Designates Congenital CMV Awareness Month to educate the public, health professionals, and expectant families about cCMV risks, prevention, screening, and early detection.

Chaptered by Secretary of State - Res. Chapter 138, Statutes of 2026.

#congenitalcytomegalovirusawarenessmonth

Summary of ACR 205 (2025-2026) – Relative to Congenital Cytomegalovirus Awareness Month

Purpose and Intent

ACR 205 designates and recognizes a Congenital Cytomegalovirus (cCMV) Awareness Month in California. The resolution is intended to raise awareness about congenital CMV, a common congenital infection that can lead to serious health issues in newborns, and to promote education and prevention efforts.

Key Provisions

Proclamation/Recognition: The measure formally designates a period (the specific month) as Congenital Cytomegalovirus Awareness Month in California.

Awareness Goals: Encourages public education about cCMV, including its effects on newborns, routes of transmission, and strategies for prevention and early detection.

Public Health Education: Calls for dissemination of information to health professionals, expectant parents, and the general public to improve understanding, screening, and timely diagnosis.

Collaboration: Encourages coordination among state agencies, healthcare providers, and community organizations to support awareness activities and resource development.

Who is Affected

General Public: Increased public awareness about cCMV and preventative practices.

Expectant Parents and Families: Greater access to information about risks and prevention.

Health Professionals: Guidance and materials to support screening, counseling, and early detection.

State Agencies and Public Health Officials: Responsible for implementing awareness activities and coordinating partners.

Procedural and Timeline Aspects

Status: As of the latest action history, the measure has progressed through committee and chamber steps:

Referred to Committee on Rules, Los Angeles and Senate committees as applicable.
Passed committee with unanimous or broad support and moved to third reading.
Cleared to move to the Senate and subsequently to the Governor or final action stage, depending on procedural timelines.

Action Timeline: Introduced May 13, 2026; advanced through May and June 2026 with standard legislative milestones (committee referral, adoption, and readings).

Additional Context

Sponsors: A broad coalition of legislators across multiple districts supports ACR 205, reflecting legislative interest in public health education and congenital CMV awareness.

Nature of Measure: As a concurrent resolution, ACR 205 expresses the sense of the Legislature and does not create new state law or budgetary changes. Its impact is primarily informational and educational, aiming to galvanize awareness and collaboration rather than mandate programmatic spending.

If you’d like, I can add a brief background on congenital CMV (what it is, prevalence, potential health impacts) to accompany this summary for readers unfamiliar with the topic.